SIGAL SMS

SIGAL SMS is a Site Management Organization (SMO) based in Germany, specializing in supporting the development, establishment, and optimization of physicians and outpatient practices for clinical research. Founded in 2014, the company aims to overcome the challenges faced by investigators and study teams, as well as sponsors and CROs, in clinical trials. With a strong network of 30 established and professional study sites across various indications, SIGAL SMS offers dedicated and solution-oriented support to achieve its clients' goals. The company's philosophy of "professional at the Site level" emphasizes standardizing modern clinical trials to an internationally recognized level. SIGAL SMS prides itself on its extensive experience in clinical trials, providing a reliable and competent partnership to navigate the individual requirements of study site establishment and professionalization. With a focus on creativity, expertise, and reliability, SIGAL SMS assists in the successful implementation of its clients' company goals. Although specific investment details are not available, SIGAL SMS's commitment to optimizing clinical research sites and its achievements in building a strong network of study sites make it a potential contender for investment opportunities in the growing field of clinical research support services. For venture capitalists seeking opportunities in the healthcare and clinical research sector, SIGAL SMS presents an intriguing potential for growth and impact within the German market.